UnitedHealth Group Incorporated $UNH Shares Purchased by Azimuth Capital Investment Management LLC

Key Points

• Azimuth Capital Investment Management increased its UnitedHealth stake by 134.3% in the second quarter, acquiring 34,568 additional shares and holding 60,311 shares valued at approximately $25.1 million.
• UnitedHealth reported quarterly EPS of $6.38, well above the $4.94 analyst consensus, and raised its 2026 adjusted EPS guidance to $19.50–$20.00. Analysts maintain a consensus “Moderate Buy” rating with an average price target of $456.56.
• Investors are weighing the company’s recovery against cost and valuation risks. UnitedHealth’s shares have rebounded significantly, while plans to reduce prior-authorization requirements could improve customer relationships but potentially pressure medical-cost controls and margins.

Azimuth Capital Investment Management LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 134.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 60,311 shares of the healthcare conglomerate's stock after purchasing an additional 34,568 shares during the quarter. UnitedHealth Group comprises about 0.8% of Azimuth Capital Investment Management LLC's portfolio, making the stock its 24th largest holding. Azimuth Capital Investment Management LLC's holdings in UnitedHealth Group were worth $25,067,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. Sarver Vrooman Wealth Advisors acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $25,000. Aberdeen Wealth Management LLC purchased a new position in shares of UnitedHealth Group in the second quarter valued at approximately $31,000. Nalls Sherbakoff Group LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $27,000. Lifetime Wealth Management P.C. purchased a new stake in UnitedHealth Group during the 4th quarter valued at about $29,000. Finally, Wilkerson Advisory Group LLC purchased a new position in UnitedHealth Group during the fourth quarter worth approximately $30,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Earnings and guidance have improved. UnitedHealth recently exceeded quarterly earnings and revenue expectations, raised its 2026 adjusted EPS outlook to $19.50–$20.00, and benefited from better medical-cost trends. Optum’s momentum and a greater focus on profitable businesses are also supporting the turnaround. UnitedHealth’s Earnings Beat And Cost Controls Could Be A Game Changer
• Positive Sentiment: Reducing prior authorizations could improve member and provider relationships. UnitedHealthcare plans to eliminate authorization requirements for roughly 1,700 services, including certain cardiology, laboratory, therapy, orthopedic and home-health procedures, beginning October 1. Less administrative friction could improve customer satisfaction, access to care and long-term retention. UnitedHealth Group To Cut Prior Authorizations For 1,700 Services
• Neutral Sentiment: Healthcare’s defensive characteristics may attract investors. Sector rotation driven by interest rates, oil prices and employment conditions could favor defensive healthcare stocks over higher-growth areas. However, analyst commentary remains mixed on whether UNH is still attractively valued after its roughly 39% six-month recovery.
• Negative Sentiment: Investors are questioning medical-cost discipline. Removing approval barriers may accelerate care and payments, but it could also weaken a key mechanism used to manage utilization and expenses. The market is watching whether faster approvals undermine margins. UnitedHealth Falls as 30% of Approval Barriers Vanish
• Negative Sentiment: Valuation leaves less room for disappointment. After a substantial rebound, UNH trades near $400 per share, leading some analysts to argue that investors have already priced in much of the recovery while margins and certain business challenges still need to improve.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.19% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have commented on UNH. DA Davidson set a $512.00 target price on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Truist Financial boosted their price target on shares of UnitedHealth Group from $440.00 to $480.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Oppenheimer boosted their price target on shares of UnitedHealth Group from $420.00 to $500.00 and gave the stock an "outperform" rating in a research note on Friday, July 17th. Royal Bank Of Canada lifted their price objective on shares of UnitedHealth Group from $463.00 to $478.00 and gave the company an "outperform" rating in a report on Friday, July 17th. Finally, BMO Capital Markets set a $512.00 target price on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $456.56.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $396.79 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The firm has a market capitalization of $356.15 billion, a P/E ratio of 25.53, a P/E/G ratio of 1.49 and a beta of 0.61. The company's fifty day moving average price is $411.65 and its 200 day moving average price is $364.16.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts' consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The business had revenue of $112.03 billion for the quarter, compared to analysts' expectations of $110.81 billion. During the same quarter in the previous year, the firm earned $4.08 earnings per share. The business's revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be issued a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 annualized dividend and a yield of 2.3%. UnitedHealth Group's payout ratio is currently 59.72%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source